Screener
Bausch Health Companies BHC Q2 2026 earnings
Reported July 29, 2026 · After market close
Revenue$2.8BBeat by $226.2M
EPS$1.26Beat by $0.30
Revenue estimate$2.6B
EPS estimate$0.96
“The second quarter marks our thirteenth consecutive quarter of year-over-year growth in Revenue and Adjusted EBITDA for Bausch Health, excluding Bausch + Lomb, reflecting the strength of our portfolio, disciplined execution, and the dedication of our teams around the world. We delivered our highest Revenue and Adjusted EBITDA growth rates in the past three years, generated our strongest Adjusted Cash Flow from Operations since Q4 2024, and reduced Net Debt by one of our largest amounts since our 2022 debt refinancing. This performance strengthens our financial flexibility and supports continued investment in our business, our pipeline, and business development opportunities. We remain focused on driving long-term value creation”
Next report
Oct 28, 2026 (in a month)Revenue estimate$2.8B
EPS estimate$1.19
Valuation & ratios
Valuation
as of 09/17/26Versus estimates
Revenue
Diluted EPS
FAQ
- When did Bausch Health Companies report Q2 2026 earnings?
- Bausch Health Companies (BHC) reported Q2 2026 earnings on July 29, 2026 after market close.
- What were Bausch Health Companies's Q2 2026 revenue and EPS?
- Bausch Health Companies reported revenue of $2.8B and eps of $1.26 for Q2 2026.
- Did Bausch Health Companies beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $2.6B by $226.2M. EPS beat the consensus estimate of $0.96 by $0.30.
- How did Bausch Health Companies's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 11.2% from $2.5B a year earlier and eps grew 40.0% from $0.90.
- Where can I find Bausch Health Companies's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0000885590-26-000105) and the 10-Q periodic report (0000885590-26-000107) directly on SEC EDGAR. The filing index links above go to sec.gov.
